The national newborn bloodspot screening programme (NNBSP) process

Hdl Handle:
http://hdl.handle.net/10147/294600
Title:
The national newborn bloodspot screening programme (NNBSP) process
Authors:
Jennings, P; Hegarty, M; Smith, L
Publisher:
Irish Medical Journal
Journal:
Irish Medical Journal
Issue Date:
Jun-2013
URI:
http://hdl.handle.net/10147/294600
Additional Links:
http://www.imj.ie/
Abstract:
The National Newborn Bloodspot Screening Programme (NNBSP) incorporates screening for several conditions where early identification helps prevent serious disability or mortality. A national group was established (2009) to plan for the inclusion of screening for cystic fibrosis (CF); as part of this process a review of the existing NNBSP was undertaken. Information was obtained through consultation with the Director of the National Newborn Bloodspot Screening Laboratory (NNBSL) and survey of maternity units (20), Local Health Office (LHO) areas (32), and practicing domiciliary midwives (16). Response rate: hospitals 100%; LHO areas 100%; domiciliary midwives 56%. Potential for strengthening quality assurance was identified e.g. single comprehensive screening register, consistent and timely procedures for checking results. Recommendations, many of which have since been implemented, included overall governance structure, liaison officer, quality assurance programme, ring-fenced funding, standardised unique identifier, dedicated laboratory IT system, secure web-based transmission of results and fail-safe method of tracking samples.
Item Type:
Article
Language:
en
Keywords:
NEWBORN SCREENING

Full metadata record

DC FieldValue Language
dc.contributor.authorJennings, Pen_GB
dc.contributor.authorHegarty, Men_GB
dc.contributor.authorSmith, Len_GB
dc.date.accessioned2013-06-26T09:05:41Z-
dc.date.available2013-06-26T09:05:41Z-
dc.date.issued2013-06-
dc.identifier.urihttp://hdl.handle.net/10147/294600-
dc.description.abstractThe National Newborn Bloodspot Screening Programme (NNBSP) incorporates screening for several conditions where early identification helps prevent serious disability or mortality. A national group was established (2009) to plan for the inclusion of screening for cystic fibrosis (CF); as part of this process a review of the existing NNBSP was undertaken. Information was obtained through consultation with the Director of the National Newborn Bloodspot Screening Laboratory (NNBSL) and survey of maternity units (20), Local Health Office (LHO) areas (32), and practicing domiciliary midwives (16). Response rate: hospitals 100%; LHO areas 100%; domiciliary midwives 56%. Potential for strengthening quality assurance was identified e.g. single comprehensive screening register, consistent and timely procedures for checking results. Recommendations, many of which have since been implemented, included overall governance structure, liaison officer, quality assurance programme, ring-fenced funding, standardised unique identifier, dedicated laboratory IT system, secure web-based transmission of results and fail-safe method of tracking samples.en_GB
dc.language.isoenen
dc.publisherIrish Medical Journalen_GB
dc.relation.urlhttp://www.imj.ie/en_GB
dc.subjectNEWBORN SCREENINGen_GB
dc.titleThe national newborn bloodspot screening programme (NNBSP) processen_GB
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen_GB
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.